STSA-1002 injection
STSA-1002 injection is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects
A Study of STSA-1002 in Healthy Subjects
Clinical Trials (6)
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects
A Study of STSA-1002 in Healthy Subjects
The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6